A phase I trial to evaluate ZD1839 [gefitinib] (Iressa[Tm]) and concurrent chemo-radiation in patients with locally advanced non small cell lung cancer [NSCLC]

Trial Profile

A phase I trial to evaluate ZD1839 [gefitinib] (Iressa[Tm]) and concurrent chemo-radiation in patients with locally advanced non small cell lung cancer [NSCLC]

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Dec 2007

At a glance

  • Drugs Carboplatin; Gefitinib; Paclitaxel
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Sponsors AstraZeneca
  • Most Recent Events

    • 18 Dec 2007 Status changed from in progress to completed.
    • 13 Jan 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top